Adial Pharmaceuticals, Inc. (ADIL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.8300-0.0200 (-1.08%)
As of 2:08PM EST. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 1.8500 |
| Open | 1.9100 |
| Bid | 1.8200 x 1800 |
| Ask | 1.8300 x 800 |
| Day's Range | 1.8000 - 1.9100 |
| 52 Week Range | 1.0000 - 4.0000 |
| Volume | 535,797 |
| Avg. Volume | 2,483,355 |
| Market Cap | 26.019M |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8230 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
We Think Adial Pharmaceuticals (NASDAQ:ADIL) Needs To Drive Business Growth Carefully
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
- ACCESSWIRE
Adial Pharmaceuticals Provides Update on its ONWARD(TM) Pivotal Phase 3 Trial of AD04 for Treatment of Alcohol Use Disorder
ONWARDâ„¢ Projected to be Fully Enrolled During Q2 2021 CHARLOTTESVILLE, VA / ACCESSWIRE / November 3, 2020 / Adial Pharmaceuticals, Inc.
- ACCESSWIRE
Todos Medical Announces Distribution Agreement with Adial Pharmaceuticals to Market the FDA, EUA Authorized, Assure/FaStep(R) Point-of-Care Covid-19 Antibody Tests
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, CHARLOTTESVILLE, VA / ACCESSWIRE / October 22, 2020 / Todos Medical (TOMDF) ("Todos"), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer's disease, along with Adial Pharmaceuticals, Inc.
© 2020 Verizon Media. All rights reserved.
